MedPath

Topotecan in Treating Patients With Recurrent Brain Tumors

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
Registration Number
NCT00003372
Lead Sponsor
NCIC Clinical Trials Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of topotecan in treating patients with recurrent brain tumor.

Detailed Description

OBJECTIVES: I. Determine the efficacy of topotecan in patients with recurrent anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma. II. Determine the qualitative and quantitative toxicity of topotecan in this patient population on this schedule.

OUTLINE: This is a multicenter study. Patients receive intravenous topotecan over 30 minutes daily for 5 days every 3 weeks. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients will be followed every 3 months until death.

PROJECTED ACCRUAL: Up to 30 evaluable patients will be accrued within 2-3 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

Tom Baker Cancer Center - Calgary

🇨🇦

Calgary, Alberta, Canada

Cross Cancer Institute

🇨🇦

Edmonton, Alberta, Canada

BC Cancer Agency

🇨🇦

Vancouver, British Columbia, Canada

CancerCare Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

Kingston Regional Cancer Centre

🇨🇦

Kingston, Ontario, Canada

Cancer Care Ontario-London Regional Cancer Centre

🇨🇦

London, Ontario, Canada

Ottawa Regional Cancer Centre - Civic Campus

🇨🇦

Ottawa, Ontario, Canada

Toronto Sunnybrook Regional Cancer Centre

🇨🇦

Toronto, Ontario, Canada

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

Centre Hospitalier de l'Universite de Montreal

🇨🇦

Montreal, Quebec, Canada

Scroll for more (1 remaining)
Tom Baker Cancer Center - Calgary
🇨🇦Calgary, Alberta, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.